Novavax COVID-19 vaccine gets emergency use approval in PH | Inquirer News
Close  

Novavax COVID-19 vaccine gets emergency use approval in PH

By: - Reporter / @DYGalvezINQ
/ 12:58 PM November 17, 2021

FILE PHOTO: A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of the displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo/File Photo

MANILA, Philippines — The Food and Drug Administration of the Philippines on Wednesday granted emergency use authorization for Covovax, the COVID-19 vaccine developed by U.S.-based biotechnology firm Novavax.

This is the ninth vaccine against COVID-19 that was granted an EUA in the Philippines, making it available for use.

ADVERTISEMENT

FDA Director-General Eric Domingo on Wednesday said the vaccine is administered in two doses with a three- to four-week interval. It was approved for use on adults 18 and above.

It has an efficacy rate of 89.7% and has reported “very mild adverse events.”

FEATURED STORIES

“Maganda ang safety profile [ng vaccine],” Domingo said in a Laging Handa public briefing.

(It’s safety profile is good.)

Domingo said Covovax is a protein-based vaccine, which is a conventional approach that uses purified pieces of the virus to spur an immune response.

/MUF

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19, COVOVAX, EUA, FDA, Novavax, vaccine
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.